Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LINDE PLCLIN · Entity 2835 | Chief Financial Officer | March 09, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LINDE PLC
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 83,094.804 |
Ending reported balance
After 2026-03-09 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-03-09 · Exercise / conversion · Acquired 8,136 · Balance 83,785.804 F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023. Row 2 · 2026-03-09 · Tax withholding · Disposed 3,771 · Balance 80,014.804 F2: Ordinary shares withheld from the payout to cover tax withholdings. Row 3 · 2026-03-09 · Exercise / conversion · Acquired 2,870 · Balance 82,884.804 F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023. Row 4 · 2026-03-09 · Tax withholding · Disposed 1,330 · Balance 81,554.804 F2: Ordinary shares withheld from the payout to cover tax withholdings. Row 5 · 2026-03-09 · Exercise / conversion · Acquired 2,870 · Balance 84,424.804 F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023. Row 6 · 2026-03-09 · Tax withholding · Disposed 1,330 · Balance 83,094.804 F2: Ordinary shares withheld from the payout to cover tax withholdings. |
| Performance Share Units (ROC)SEC Table II · derivative / convertible security | Direct | 8,136 |
Reported balance
After 2026-03-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-03-09 · Grant · Acquired 8,136 · Balance 8,136 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Performance Share Units (ROC)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-03-09 · Exercise / conversion · Disposed 8,136 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Performance Share Units (RTSR)SEC Table II · derivative / convertible security | Direct | 2,870 |
Reported balance
After 2026-03-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-03-09 · Grant · Acquired 2,870 · Balance 2,870 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Performance Share Units (RTSR)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-03-09 · Exercise / conversion · Disposed 2,870 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,098 |
Reported balance
After 2026-03-09 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-03-09 · Grant · Acquired 3,098 · Balance 3,098 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-03-09 · Exercise / conversion · Disposed 2,870 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,728 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 2,728 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,625 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 2,625 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $483.62 · Expires 2036-03-09 | Direct | 25,259 |
Reported balance
After 2026-03-09 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2026-03-09 · Grant · Acquired 25,259 · Balance 25,259 F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07 | Direct | 19,156 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 19,156 F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07 | Direct | 17,015 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 17,015 F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07 | Direct | 18,970 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 18,970 F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07 | Direct | 22,535 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 22,535 F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08 | Direct | 34,320 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 34,320 F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09 | Direct | 43,695 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 43,695 F16: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20 | Direct | 47,020 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 47,020 F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27 | Direct | 64,665 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · Balance 64,665 F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28 | Direct | 72,795 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · Balance 72,795 F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
| Ordinary SharesSEC Table I · non-derivative | Indirect401(k) | 3,096.221 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 3,096.221 |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,541.952 |
Reported balance
Holding disclosure · report date 2026-03-09 · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · Balance 1,541.952 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F18: Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023.
F2: Ordinary shares withheld from the payout to cover tax withholdings.
F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023.
F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
F16: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
F18: Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PRAXAIR INC
Report date October 31, 2018 · Filed November 01, 2018
Section 16 reporting ended · disclosed 2018-11-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirect401(k) | 0 |
Reported balance
After 2018-10-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-10-31 · Disposition to issuer · Disposed 2,732.9991 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 2
1 source rowRow 2 · 2018-10-31 · Disposition to issuer · Disposed 16,611 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-10-31 · Disposition to issuer · Disposed 7,765 · Balance 0 F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-31 · Disposition to issuer · Disposed 6,054 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-31 · Disposition to issuer · Disposed 7,960 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-10-31 · Disposition to issuer · Disposed 6,191 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-10-31 · Disposition to issuer · Disposed 5,450 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.92 · Expires 2019-02-24 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-10-31 · Disposition to issuer · Disposed 20,290 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.16 · Expires 2020-02-23 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-10-31 · Disposition to issuer · Disposed 13,640 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2021-02-22 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-10-31 · Disposition to issuer · Disposed 14,845 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-10-31 · Disposition to issuer · Disposed 18,430 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-10-31 · Disposition to issuer · Disposed 15,060 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-10-31 · Disposition to issuer · Disposed 31,090 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2018-10-31 · Disposition to issuer · Disposed 40,865 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2018-10-31 · Disposition to issuer · Disposed 85,205 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2018-10-31 · Disposition to issuer · Disposed 72,795 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27 | Direct | 0 |
Reported balance
After 2018-02-27 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2018-02-27 · Disposition to issuer · Disposed 64,665 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2018-10-31 · Disposition to issuer · Disposed 732.164 · Balance 0 F9: Conversion to Praxair Common Stock is on a 1-for-1 basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F10: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
F9: Conversion to Praxair Common Stock is on a 1-for-1 basis.
F10: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2018 Filed Nov 1, 2018 22:15 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 7,765 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 3 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,765 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F2 · derivative.exercise_date: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 22:15 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerCommon Stock | 16,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000078 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 22:15 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerCommon Stock | 2,732.9991 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000078 · edgar.xml · nonDerivative · entry 1 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Disclosed balance after: 0 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock · Derivative | 115.399 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · derivative · entry 17 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720.728 Underlying: Common Stock · 720.728 shares Expires not disclosed F9 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F10 · derivative.exercise_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. F10 · derivative.expiration_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 64,665 | $0.00 Strike: $154.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · derivative · entry 7 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,665 Underlying: Common Stock · 64,665 shares Expires 2028-02-27 F5 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 7,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · nonDerivative · entry 4 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,376 F3 · shares: Restricted stock unit award granted on February 27, 2018, payable in shares of Praxair Common Stock, vesting 100% on February 27, 2021. Read SEC document |
| February 27, 2018 Filed Nov 1, 2018 22:15 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerStock Option (right to buy) · Derivative | 64,665 | $0.00 Strike: $154.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 17 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,665 shares Expires 2028-02-27 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8 · price: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F8 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionPerformance Share Units · Derivative | 2,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · derivative · entry 6 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,303 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_price: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · price: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_date: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.expiration_date: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | GrantPerformance Share Units · Derivative | 2,303 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · derivative · entry 5 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,303 Underlying: Common Stock · 2,303 shares Expires not disclosed F4 · derivative.exercise_price: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · price: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.exercise_date: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. F4 · derivative.expiration_date: The PSU Paid out on February 26, 2018 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2015-2017 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2015. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 1,068 | $155.62 | $166,202.16 |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · nonDerivative · entry 3 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,611 F2 · shares: Shares of common stock withheld from the PSU payout to cover tax withholdings. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 21:06 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 2,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000016 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 24, 2015 (the "PSU"). Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 10,800 | $0.00 Strike: $83.89 | $0.00 |
DisclosureSEC source: 0000884905-17-000040 · edgar.xml · derivative · entry 7 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,800 shares Expires 2018-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionStock Option (right to buy) · Derivative | 7,200 | $0.00 Strike: $83.39 | $0.00 |
DisclosureSEC source: 0000884905-17-000040 · edgar.xml · derivative · entry 6 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,200 shares Expires 2018-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 8,970 | $125.71 | $1,127,618.70 |
DisclosureSEC source: 0000884905-17-000040 · edgar.xml · nonDerivative · entry 5 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,376 F2 · shares: Shares withheld from option exercise to pay the option exercise price and taxes. No market sale of shares occurred. The reporting person acquired and held 1,830 shares net of the shares withheld. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 10,800 | $83.89 | $906,012.00 |
DisclosureSEC source: 0000884905-17-000040 · edgar.xml · nonDerivative · entry 4 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 5,831 | $125.70 | $732,956.70 |
DisclosureSEC source: 0000884905-17-000040 · edgar.xml · nonDerivative · entry 3 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,546 F1 · shares: Shares withheld from option exercise to pay the option exercise price and taxes. No market sale of shares occurred. The reporting person acquired and held 1,369 shares net of the shares withheld. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 7,200 | $83.89 | $604,008.00 |
DisclosureSEC source: 0000884905-17-000040 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 13:41 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock · Derivative | 137.012 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000021 · edgar.xml · derivative · entry 3 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591.246 Underlying: Common Stock · 137.012 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. F2 · derivative.expiration_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 21:17 UTC | PRAXAIR INC PX · Entity 162268 | GrantStock Option (right to buy) · Derivative | 72,795 | $0.00 Strike: $118.71 | $0.00 |
DisclosureSEC source: 0000884905-17-000008 · edgar.xml · derivative · entry 6 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,795 Underlying: Common Stock · 72,795 shares Expires 2027-02-28 F4 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:17 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionPerformance Share Units · Derivative | 1,998 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000884905-17-000008 · edgar.xml · derivative · entry 5 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). F3 · price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.expiration_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F1 · derivative.underlying_shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:17 UTC | PRAXAIR INC PX · Entity 162268 | GrantPerformance Share Units · Derivative | 1,998 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000008 · edgar.xml · derivative · entry 4 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,998 Underlying: Common Stock · 1,998 shares Expires not disclosed F3 · security: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · price: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.exercise_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. F3 · derivative.expiration_date: The PSU paid out on February 27, 2017 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Praxair, Inc. from 2014-2016 measured against ROC goals set by the Compensation and Management Development Committee of the Board of Directors when the PSU was granted in 2014. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:17 UTC | PRAXAIR INC PX · Entity 162268 | Tax withholdingCommon Stock | 687 | $118.11 | $81,141.57 |
DisclosureSEC source: 0000884905-17-000008 · edgar.xml · nonDerivative · entry 3 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,177 F2 · shares: Shares of common stock withheld from the PSU payout to cover tax withholdings. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:17 UTC | PRAXAIR INC PX · Entity 162268 | Exercise / conversionCommon Stock | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000008 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on February 25, 2014 (the "PSU"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.